Alexandria, Va.—The ASCO Cancer Foundation will award $7.6 million to support clinical and translational research designed to improve cancer prevention, treatment and care. The grants will be awarded to 62 researchers and three community oncology practices at the American Society of Clinical Oncology's 44th Annual Meeting in Chicago, May 31 – June 3.
Alexandria, Va.—In the first study to assess mammography in women 80 and older, researchers found that having regular mammograms significantly decreases the risk of being diagnosed with late-stage breast cancer, but only about one-fifth of women in this age group receive them regularly.
Alexandria, Va.—A multicenter phase III clinical trial has reported that the drug letrozole cuts the risk of breast cancer recurrence by 63 percent and the risk of cancer spread by 61 percent in postmenopausal women with early-stage disease who completed five years of tamoxifen therapy one to seven years earlier. The study is being published online March 10 in the Journal of Clinical Oncology (JCO).
Alexandria, Va.—Douglas W. Blayney, MD, an internationally recognized expert in oncology quality and informatics, and hematologic malignancy, has been elected to become President of the American Society of Clinical Oncology (ASCO) for a one-year term beginning in June 2009. He will take office as President-Elect during ASCO’s 44th Annual Meeting in Chicago in June 2008. Additionally, four new members were elected to the ASCO Board of Directors and two new members to the ASCO Nominating Committee, all for three-year terms beginning in June 2008.
SAN FRANCISCO, Ca. – New research on the treatment of genitourinary cancers is being presented at the first Genitourinary Cancers Symposium, being held February 14-16, 2008, at the San Francisco Marriott. A media presscast highlighting the noteworthy studies summarized below can be accessed at www.asco.org/GUpresskit08.
Presscast (press briefing via live webcast) to release new research being presented at the Genitourinary Cancers Symposium. The symposium, being held February 14-16 in San Francisco, will bring together more than 1,500 participants and feature nearly 500 abstracts.
In conjunction with the 2008 Genitourinary Cancers Symposium taking place February 14 – 16 at the San Francisco Marriott, the Cancer Foundation of the American Society of Clinical Oncology (ASCO) is pleased to present a free public forum on genitourinary (GU) cancers.
Alexandria, Va.— The winners of the 2008 Genitourinary (GU) Cancers Symposium Merit Awards were announced today. Twenty-five physicians-in-training from around the world will receive a Merit Award for their notable research contributions in genitourinary cancers. These young investigators will receive funding to assist with their travel expenses to attend the Symposium scheduled for February 14-16 in San Francisco.
Alexandria, Va. – Key research on the prevention and treatment of testis, bladder, kidney and prostate cancers will be the focus of the first bi-annual Genitourinary Cancers Symposium press program. Study authors will discuss notable research in an embargoed presscast (press briefing via live webcast) on Tuesday, February 12 from 1:00 to 2:00 PM (EST).
Orlando, Fla. – New research on the treatment of gastrointestinal cancers is being presented at the 5th annual Gastrointestinal Cancers Symposium, being held January 25-27 at the Orlando World Center Marriott. The presscast highlighting noteworthy studies can be accessed at www.asco.org/GIpresskit08.
